Lidocaine EP Impurity I

Chromatographic Determination of Aminoacridine Hydrochloride, Lidocaine Hydrochloride and Lidocaine Toxic Impurity in Oral Gel
Lories I. Bebawy1, Mohamed R. Elghobashy2, Samah S. Abbas2, and Rafeek F. Shokry
Journal of Chromatographic Science, 2016, Vol. 54, No. 4, 492–499
 
Development, Validation and Application of a Stability Indicating HPLC Method to Quantify Lidocaine from Polyethylene-co-Vinyl Acetate (EVA) Matrices and Biological Fluids
Prabhat Bhusal, Manisha Sharma, Jeff Harrison, Georgina Procter, Gavin Andrews, David S. Jones, Andrew G. Hill, Darren Svirskis
Journal of Chromatographic Science, Volume 55, Issue 8, September 2017, Pages 832–838
 
Development of the HPLC Method for Simultaneous Determination of Lidocaine Hydrochloride and Tribenoside Along with Their Impurities Supported by the QSRR Approach
Alina Plenis,Lucyna Konieczna,Natalia Mie˛kus,Tomasz Ba˛czek
Chromatographia (2013) 76:255–265

Lidocaine EP Impurity I is chemically 2-(Diethylamino)-N-(2,4-dimethylphenyl)acetamide hydrochloride (as per EP). It is also known as Lidocaine 2,4-Dimethyl Analog. Lidocaine EP Impurity I is supplied with detailed characterization data compliant with regulatory guideline. Lidocaine EP Impurity I can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lidocaine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.